Search - tctmd.com

Displaying 141 - 160 of 326

Sort: Relevancy | Date

News Daily News

一项元分析对在STEMI患者中采取的“一刀切”式的抗凝血剂策略提出了质疑

L.A. McKeown

November 17, 2014

News Daily News

Un Meta Análisis Cuestiona la Estrategia Anticoagulante ‘Talla Única’ en Pacientes STEMI

L.A. McKeown

November 17, 2014

News Conference News AHA 2014

Registry: Newer P2Y12 Inhibitors Reduce Stent Thrombosis, Mortality Over Clopidogrel

Yael L. Maxwell

November 17, 2014

News Daily News

Meta-analysis Questions One-Size-Fits-All Anticoagulant Strategy in STEMI Patients

L.A. McKeown

November 17, 2014

News Daily News

El Uso Crónico de un Antagonista de la Vitamina K Aumenta las Hemorragias Intrahospitalarias en Pacientes sometidos a PCI Primarias

Caitlin E. Cox

November 02, 2014

News Daily News

Chronic Vitamin K Antagonist Use Ups In-Hospital Bleeding Among Primary PCI Patients

Caitlin E. Cox

November 02, 2014

News Daily News

HORIZONS-AMI Substudy: Women at Higher Risk for Bleeding After STEMI

Yael L. Maxwell

October 03, 2014

News Daily News

Subestudio del HORIZONS-AMI: Las Mujeres Corren Más Riego Hemorrágico Post-STEMI

Yael L. Maxwell

October 03, 2014

News Conference News TCT 2014

Post-procedural Consent in STEMI Trials Debated

September 15, 2014

News Industry News

Extended Follow-Up of Multicenter Trial Demonstrates Continued Superiority of Bivalirudin to Heparin with and without Glycoprotein IIB, IIIA Inhibition in Patients with Acute Myocardial Infarction

September 15, 2014

News Conference News TCT 2014

EUROMAX Substudy: Bivalirudin Noninferior to Heparin Plus GPI for Myocardial Reperfusion

September 14, 2014

News Conference News TCT 2014

Study Identifies Predictors of Stent Thrombosis, Mortality After Primary PCI

September 13, 2014

News Conference News TCT 2014

Meta-analysis: Less Bleeding, More Stent Thrombosis with Bivalirudin vs. Heparin After PCI

September 13, 2014

News Daily News

European Societies Release Updated Revascularization Guidelines for CAD

L.A. McKeown

September 11, 2014

News Daily News

Las Sociedades Europeas Publican Directrices Actualizadas sobre Revascularización en el Manejo de EAC

L.A. McKeown

September 11, 2014

News Daily News

Subestudio del HORIZONS-AMI: La Anticoagulación Primaria Post-PCI Da Peores Resultados

September 02, 2014

News Daily News

HORIZONS-AMI亚组研究：直接PCI后抗凝血产生的结果更差

September 02, 2014

News Daily News

HORIZONS-AMI Substudy: Anticoagulation After Primary PCI Yields Worse Outcomes

September 02, 2014

News Conference News ESC 2014

BIOSCIENCE: Biodegradable Polymer SES Noninferior to Durable Polymer EES in All-Comers Trial

Yael L. Maxwell

September 01, 2014

News Industry News

Regado Biosciences Permanently Halts REGULATE-PCI Clinical Trial

August 25, 2014

Advertisement

一项元分析对在STEMI患者中采取的“一刀切”式的抗凝血剂策略提出了质疑

Un Meta Análisis Cuestiona la Estrategia Anticoagulante ‘Talla Única’ en Pacientes STEMI

Registry: Newer P2Y12 Inhibitors Reduce Stent Thrombosis, Mortality Over Clopidogrel

Meta-analysis Questions One-Size-Fits-All Anticoagulant Strategy in STEMI Patients

El Uso Crónico de un Antagonista de la Vitamina K Aumenta las Hemorragias Intrahospitalarias en Pacientes sometidos a PCI Primarias

Chronic Vitamin K Antagonist Use Ups In-Hospital Bleeding Among Primary PCI Patients

HORIZONS-AMI Substudy: Women at Higher Risk for Bleeding After STEMI

Subestudio del HORIZONS-AMI: Las Mujeres Corren Más Riego Hemorrágico Post-STEMI

Post-procedural Consent in STEMI Trials Debated

Extended Follow-Up of Multicenter Trial Demonstrates Continued Superiority of Bivalirudin to Heparin with and without Glycoprotein IIB, IIIA Inhibition in Patients with Acute Myocardial Infarction

EUROMAX Substudy: Bivalirudin Noninferior to Heparin Plus GPI for Myocardial Reperfusion

Study Identifies Predictors of Stent Thrombosis, Mortality After Primary PCI

Meta-analysis: Less Bleeding, More Stent Thrombosis with Bivalirudin vs. Heparin After PCI

European Societies Release Updated Revascularization Guidelines for CAD

Las Sociedades Europeas Publican Directrices Actualizadas sobre Revascularización en el Manejo de EAC

Subestudio del HORIZONS-AMI: La Anticoagulación Primaria Post-PCI Da Peores Resultados

HORIZONS-AMI亚组研究：直接PCI后抗凝血产生的结果更差

HORIZONS-AMI Substudy: Anticoagulation After Primary PCI Yields Worse Outcomes

BIOSCIENCE: Biodegradable Polymer SES Noninferior to Durable Polymer EES in All-Comers Trial

Regado Biosciences Permanently Halts REGULATE-PCI Clinical Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content